showcasing 10 outstanding impact enterprises who are currently seeking additional capital to scale both their business and impacts. We will be organizing the virtual pitching event on Zoom, which will take
for long-time outstanding receivables in accordance with IFRS 9 (Financial -2- Instruments), which was partly due to the effect of COVID-19 causing the receivables to postpone payment; but when compare
Bangchak Corporation Plc. Management Discussion & Analysis of Business Operation For the 4th quarter and year ended December 31th, 2019 2 Management Discussion and Analysis of Business Operation for FY2019 Bangchak Corporation Plc. | 03 Table of Contents 06 09 29 25 27 31 Executive Important Events Summary Business Performance 11 - Refinery & Trading 16 - Marketing 19 - Power Plant 21 - Bio-based Products 23 - Natural Resources Statement of Cash Flows Statement Financial Ratios Environment Manag...
), representing 89.12% of the total issued and outstanding shares in Permata (the Transaction) in accordance with the resolution of the Board of Directors’ Meeting No. 12/2019, given on 11 December 2019. Each of
prevention making it possible to complete the project even more. In addition, the several large-scale projects were due for delivery in this quarter such as the Purchasing and Installation of Cloud Project of
of scale. VGM Business Overview* *More commentary on the VGM transaction can be found in Report on http://maco.listedcompany.com/newsroom/270620181831240885E.pdf, http://maco.listedcompany.com/newsroom
impact investor networks. This virtual pitching event will be showcasing 10 outstanding impact enterprises who are currently seeking additional capital to scale both their business and impacts. We will be
the following factors: 1) gradual relaxation of COVID-19 epidemic control measures and progress in vaccination 2) the impact of outstanding demand from the previous quarter and 3) government policies
” (TFRS9). Summary of Operation for Q4-2020 Topic Outstanding by Quarter Change Q4 – 20 Q3 – 20 Q4 – 19 Q4 – 20 VS Q3 – 20 Q4 – 20 VS Q4 – 19 (MB) (MB) % (MB) % Total Revenue 2,070.7 2,241.1 2,280.3 (170.4
IPD which generated highest margin comparing to other categories. Moreover, the efficient cost management such as medicine & medical supplies as well as the benefit from economy of scale in term of